Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 2, 1996, Pages 375-385

  Prasad, Kailash ^a   Gupta, Jang B ^b   Kalra, Jawahar ^b   Lee, P ^b   Mantha, Subrahmanyam V ^b   Bharadwaj, Baikunth ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b NONE

Author keywords

Antioxidant enzymes; Heart failure; Malondialdehyde; Oxyradicals; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART LEFT ATRIUM PRESSURE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE OVERLOAD; LIPID PEROXIDATION; MALE; MITRAL VALVE REGURGITATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 0029876316     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0035     Document Type: Article

References (56)

1. AEBI H, 1974. Catalase. In: HV Bergmeyer, ed., Methods of Enzymatic Analysis. Chemie: Weinheim, F.R.G, 673-684.
2. BONAVIDA B, MENCIA-HUERTA JM, BRAQUET P, 1989. Effect of platelet-activating factor (PAF) on monocyte activation and production of tumor necrosis factor (TNF). Int Arch Allergy Appl Immunol 88: 157-160.
3. BRAQUET P, HOSFARD D, BRAQUET M, BOURGAIN R, BUSSOLINO F, 1989. Role of cytokines and platelet-activating factor in microvascular immune injury. Int Arch Allergy Appl Immunol 88: 88-100.
4. BURTON GW, INGOLD KU, 1989. Vitamin E as an in vitro and in vivo antioxidant. Ann N Y Acad Sci 570: 7-22.
5. BURTON GW, JOYCE A, INGOLD KU, 1983. Is vitamin E the only lipid soluble, chain breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys 221: 281-290.
6. CADENAS E, VARSAVSKY AI, BOVERIS A, CHANCE B, 1981a. Oxygen or organic hydroperoxide-induced chemiluminescence of brain and liver homogenates. Biochem J 198: 645-654.
7. CADENAS E, WEFERS H, SIES H, 1981b. Low level chemiluminescence of isolated hepatocytes. Eur J Biochem 119:531-536.
8. CADENAS E, SIES H, 1982. Low level chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide: relation to microsomal hemoproteins, oxygen dependence, and lipid peroxidation. Eur J Biochem 124: 349-356.
9. CHAMBERS DE, PARKS DA, PATTERSON G, ROY R, MCCORD JM, YOSHIDA S, PARMLEY LF, DOWNEY JM, 1985. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 17: 145-152.
10. DZAU VJ, PACKER M, LILLY LS, SWARTZ SL, HOLLENBERGER NK, WILLIAMS GH, 1984. Prostaglandins in severe congestive heart failure. Relation to activation of renin-angiotensin system and hyponatremia. N Engl J Med 310: 347-352.
11. 4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286: 264-267.
12. GOLDFARB AH, 1993. Antioxidants: role of supplementation to prevent exercise-induced oxidative stress. Med Sci Sports Exerc 25: 232-236.
13. GRAHAM DG, TIFFANY SM, BELL WR, GUTKNECHT WF, 1978. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward Cl300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644-653.
14. GUARNIERI C, FLAMIGNI F, CALDARERA CM, 1980. Role of oxygen in the cellular damage induced by reoxygenation of hypoxic heart. J Mol Cell Cardiol 12: 797-808.
15. HEARSE DJ, MANNING AS, DOWNEY JM, YELLON DM, 1986. Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand [Suppl.] 548: 65-78.
16. HESS ML, OKABE E, KONTOS HA, 1981. Proton and free oxygen radical interaction with the calcium transport system of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 13: 767-772.
17. JENNINGS RB, REIMER KA, 1982. Lethal myocardial ischemic injury. Am J Pathol 102: 241-255.
18. ++ pump by oxygen free radicals. Am J Physiol 257: H804-H811.
19. KAPOOR R, PRASAD K, 1994. Role of oxyradicals in cardiovascular depression and cellular injury in hemmorhagic shock and reinfusion: Effect of SOD and catalase. Circ Shock 43: 79-94.
20. LAWRENCE RA, BURK RF, 1976. Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 71: 952-958.
21. LEFER AM, 1989. Platelet-activating factor (PAF) and its role in cardiac injury. Progr Clin Biol Res 301: 53-60.
22. LEPRAN I, LEFER M, 1985. Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. Basic Res Cardiol 80: 135-141.
23. LEVENSON DJ, SIMMONS CE, BRENNER BM, 1982. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med 72: 354-374.
24. LEVINE TB, FRANCIS GS, GOLDSMITH SR, SIMON A, COHN JN, 1982. Activity of sympathetic nervous system and renin angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49: 1659-1666.
25. LEVINE B, KALMAN J, MAYER L, FILLIT HM, PACKER M, 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Eng J Med 323:236-241.
26. MAIORINO M, COASSIN M, ROVERI A, URSINI F, 1989. Microsomal lipid peroxidation : Effect of vitamin B and its functional interaction with phospholipid hydroperoxide glutathione peroxidase. Lipids 24: 721-726.
27. MANTHA SV, PRASAD M, KALRA J, PRASAD K, 1993. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis 101: 135-144.
28. MUROTA SI, MORITA I, SUDA N, 1990. The control of vascular endothelial cell injury. Ann NY Acad Sci 598: 182-187.
29. NASJLETTI A, MALIK KU, 1981. Interrelationships among prostaglandins and vasoactive substances. Med Clin North Am 65: 881-889.
30. OHKAWA H, OHISHI N, YAGI K, 1979. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
31. PANGANAMALA RV, SHARMA HM, HEIKKILA JC, GEER JC, CORNWELL DG, 1976. Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis. Prostaglandins 11: 599-607.
32. PAUBERT-BRAQUET M, LONGCHAMPS MO, KOLZ P, 1988. Tumor necrosis factor (TNF) primes human neutrophil (PMN) platelet-activating factor (PAF)-induced superoxide generation. Consequences in promoting PMN-mediated endothelial cell (EC) damages (abstract). Prostaglandins 35: 803.
33. PIGNOL B, HENANE S, MENCIA-HUERTA JM, ROLAPLESZCZYNSKI M, BRAQUET P, 1987. Effect of PAF-acether (platelet-activating factor) and its specific antagonist, BN51021, on interleukin 1 (IL-1) release and synthesis by rat skin adherent monocytes. Prostaglandins 33: 931-939.
34. PRASAD K, KHATTER JC, BHARADWAJ B, 1977. Cardiovascular function in experimental mitral insufficiency in dogs. Jpn Heart J 18: 823-840.
35. PRASAD K, O'NEIL CL, BHARADWAJ B, 1984. Effects of chronic digoxin treatment on cardiac function, electrolytes and sarcolemmal ATPase in the canine failing heart due to chronic mitral regurgitation. Am Heart J 108: 1487-1494.
36. PRASAD K, O'NEIL CL, BHARADWAJ B, 1985. Effect of chronic prazosin treatment on cardiac function and electrolytes in failing heart due to chronic mitral insufficiency. Can J Cardiol 2: 107-112.
37. PRASAD K, KALRA J, BHARADWAJ B, 1989a. Increased chemiluminescence of polymorphonuclear leukocytes in dogs with volume overload heart failure. Br J Exp Pathol 70: 463-468.
38. PRASAD K, KALRA J, CHAN WP, CHAUDHARY AK, 1989b. Effect of oxygen free radicals on cardiovascular function at organ and cellular level. Am Heart J 117: 1196-1202.
39. PRASAD K, KALRA J, MASSEY KL, BHARADWAJ B, 1989c. Increased production of oxygen free radicals by polymorphonuclear leukocytes in heart failure due to aortic stenosis. Angiology 40: 472-478.
40. PRASAD K, KALRA J, CHAUDHARY AK, DEBNATH D, 1990. Effect of polymorphonuclear leukocyte derived-oxygen free radicals and hypochlorous acid on cardiac function and some biochemical parameters. Am Heart J 119: 538-550.
41. PRASAD K, LEE P, KALRA J, 1991. Influence of endothelin on cardiovascular function, oxygen free radicals, and blood chemistry. Am Heart J 121: 178-187.
42. PRASAD K, KAPOOR R, KALRA J, 1992. Methionine in protection of hemorrhagic shock: Role of oxygen free radicals and hypochlorous acid. Circ Shock 36: 265-276.
43. PRASAD K, LEE P, MANTHA SV, KALRA J, PRASAD M, GUPTA JB, 1992. Detection of ischemia-reperfusion cardiac injury by cardiac chemiluminescence. Mol Cell Biochem 115:49-58.
44. PRASAD K, KALRA J, 1993. Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of Vitamin E Am Heart J 125: 958-973.
45. PRASAD K, KALRA J, BHARADWAJ L, 1993. Cardiac depressant effects of oxygen free radicals. Angiology 44: 257-270.
46. PRASAD K, KALRA J, LEE P, 1994. Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of probucol. Int J Angiol 3: 100-112.
47. SINGAL PK, KAPUR N, DHILLON KS, BEAMISH RE, DHALLA NS, 1982. Role of free radicals in catecholamine induced cardiomyopathy. Can J Physiol Pharmacol 60: 1390-1397.
48. STEWARD AG, DUBBIN PN, HARRIS T, DUSTINS GJ, 1990. Platelet-activating factor may act as second messenger in the release of eicosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 87: 3215-3219.
49. SUN Y, PETERSON TE, MCCORMICK ML, OBERLEY LW, OSBORNE JW, Improved superoxide dismutase assay for clinical use. Clin Chem 35: 1265-1266.
50. THOMAS JA, MARKS BH, 1978. Plasma norepinephrine in congestive heart failure. Am J Cardiol 41: 233-243.
51. VANDEN BOSCH H, 1980. Intracellular phospholipase A. Biochem Biophys Acta 604: 191-246.
52. WATKINS U, BURTON JA, HABER E, CANT JR, SMITH FM, BARGER AC, 1976. The renin-aldosterone system in congestive heart failure in conscious dogs. J Clin Invest 57: 1606-1617.
53. 5a des Arg on neutrophil function. Immunopharmocology 2: 201-219.
54. YANG SS, BENTIVOGLIO LG, MARANHAO V, GOLDBERG H, 1972. From Cardiac Catheterization Data toHemodynamic Parameters. FA Davis : Philadelphia, 157-210.
55. YOUNG IS, PURVIS JA, LIGHTBODY JH, ADGEY AAJ, TRIMBLE ER, 1993. Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction. Eur Heart J 14: 1027-1033.
56. ZORATTI EM, SEDGWICH JB, VRTIS RR, BUSSE WW, 1991. The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophil. J Allergy Clin Immonol 88: 749-758.